The production of molybdenum-99 at the High Flux Reactor in Petten, the Netherlands, is unlikely to restart in February 2009 as had been planned, according to the facility’s operators, the Nuclear Research and Consultancy Group.
The production of molybdenum-99 at the High Flux Reactor in Petten, the Netherlands, is unlikely to restart in February 2009 as had been planned, according to the facility's operators, the Nuclear Research and Consultancy Group.
The HFR, one of two main sources of Mo-99 in Europe, has been out of action since mid-August when gas bubbles were found escaping into the reactor's cooling system. The cause of the leak was subsequently traced to corrosion between an external pipe and its concrete casing.
Engineers hope to seal the leak by inserting a sleeve into the pipe. But when a detailed repair plan was drawn up, it became evident that the process would take much longer than expected.
"The placement of a sleeve into the cooling system cannot be completed by mid-February as earlier anticipated but will take a few months longer," a spokesperson for the NRG told Diagnostic Imaging. "This extra time is necessary to complete the required qualification of materials and testing of the application procedures."
The NRG is now investigating whether the HFR could be restarted at an earlier date using unspecified "alternative measures."
Nuclear medicine services throughout Europe have already faced disruption to supplies of technetium-99m, the daughter nuclide of Mo-99, while the HFR has been offline. Another crunch in Tc-99m availability is expected in early January when imaging services resume their normal workloads after the holiday break.
Europe's other main producer of Mo-99, the BR-2 reactor in Mol, Belgium, closed for routine maintenance on Dec. 10 and will not restart until Jan. 13, 2009.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.